Seres Therapeutics, Inc. (MCRB) Total liabilities 2016–2025
Seres Therapeutics, Inc. (MCRB) total liabilities at each fiscal year-end, per SEC filings.
$94.0MFY2025 · since FY2016: $140.0M → $94.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $94.0M | -25.4% |
| FY2024 | $126.0M | -68.8% |
| FY2023 | $403.5M | +19.4% |
| FY2022 | $338.0M | +51.3% |
| FY2021 | $223.4M | +32.8% |
| FY2020 | $168.2M | -7.0% |
| FY2019 | $180.8M | +7.3% |
| FY2018 | $168.5M | +30.8% |
| FY2017 | $128.8M | -8.0% |
| FY2016 | $140.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice